Company Filing History:
Years Active: 2014-2015
Title: Ken Poppleton: Innovator in Artificial Heart Technology
Introduction
Ken Poppleton is a notable inventor based in Salt Lake City, Utah. He has made significant contributions to the field of artificial heart technology, holding two patents that showcase his innovative approach to medical devices. His work focuses on utilizing artificial neural networks to enhance the functionality and predictability of artificial hearts.
Latest Patents
Ken Poppleton's latest patents include systems and methods for predicting characteristics of an artificial heart using an artificial neural network. These systems are designed to predict various characteristics of an artificial heart by employing a processor and memory in electronic communication with the processor. The artificial neural network receives an input vector of a predetermined length to train itself, producing an output vector based on the input. The system compares the output vector with a target vector of the same length. If the output does not match the target vector within a predetermined error rate, the network adjusts at least one weight. Conversely, when the output matches the target vector within the error rate, the network executes the input vector to estimate at least one characteristic of the artificial heart.
Career Highlights
Ken Poppleton is currently associated with World Heart Corporation, where he applies his expertise in artificial heart technology. His work has been instrumental in advancing the capabilities of artificial hearts, making them more reliable and efficient for patients in need of cardiac support.
Collaborations
Ken collaborates with W Kurt Dobson, a fellow innovator in the field. Their combined efforts contribute to the ongoing development of cutting-edge technologies in artificial heart systems.
Conclusion
Ken Poppleton's contributions to artificial heart technology through his innovative patents and collaborations highlight his commitment to improving medical devices. His work continues to pave the way for advancements in cardiac care, ultimately benefiting patients worldwide.